TY - JOUR
AU - H. Luderer
AU - N. Enman
AU - R. Gerwien
AU - S. Braun
AU - S. McStocker
AU - X. Xiong
AU - C. Koebele
AU - C. Cannon
AU - J. Glass
AU - Y. Maricich
A1 - 
AD - Pear Therapeutics (US), Inc, Boston, MA, United States.; Whitman-Walker Institute, Washington, DC, United States.; Kaiser Permanente Washington Health Research Institute, Seattle, WA, United States.
AN - 36662568
BT - JMIR Res Protoc
C5 - Opioids & Substance Use; Measures;
DA - Jan 20
DO - 10.2196/43122
DP - NLM
ET - 20230120
JF - JMIR Res Protoc
LA - eng
PY - 2023
SN - 1929-0748 (Print); 1929-0748
SP - e43122
ST - A Prescription Digital Therapeutic to Support Unsupervised Buprenorphine Initiation for Patients With Opioid Use Disorder: Protocol for a Proof-of-Concept Study
T1 - A Prescription Digital Therapeutic to Support Unsupervised Buprenorphine Initiation for Patients With Opioid Use Disorder: Protocol for a Proof-of-Concept Study
T2 - JMIR Res Protoc
TI - A Prescription Digital Therapeutic to Support Unsupervised Buprenorphine Initiation for Patients With Opioid Use Disorder: Protocol for a Proof-of-Concept Study
U1 - Opioids & Substance Use; Measures;
U3 - 10.2196/43122
VL - 12
VO - 1929-0748 (Print); 1929-0748
Y1 - 2023
ER -